Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
Daily MedNews
-- Here are the latest clinical trials, courtesy of CenterWatch:
Sleep Disorders
If you are aged 18 to 65, in good general health, and wake up multiple times during a typical night, you may qualify for this study.
The research site is in Las Vegas,...
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Trauma During Pregnancy Boosts Risk of Schizophrenia in Kids
There's an increased risk of schizophrenia among children born to women who experience...
THURSDAY, Aug. 21 -- If your child won't take medicine and shuns broccoli at the dinner table, his body may just be hard-wired to respond that way.
"Kids reject the bad taste of medicine, because it's basic biology. Their system is designed to...
THURSDAY, Aug. 21 -- Some parents' refusal to vaccinate children seems to be behind the highest rate of measles cases reported since 1996, federal officials said Thursday.
Between Jan. 1 and July 31 of this year, 131 measles cases have been reported...
THURSDAY, Aug. 21 -- Dawn Marie Perkins wasn't even seven months pregnant with her twin boys when she knew something had gone terribly wrong.
After numerous tests and evaluations, Perkins quickly learned that strokes aren't something that just...
Pharma Industry News
NEW YORK--(BUSINESS WIRE)--Aug 21, 2008 - The 2009 Segal Health Plan Cost Trend Survey forecasts continued declines in trends for 2009, marking the sixth consecutive year of declining trends. Most trend rates are projected to be lower in 2009 than...
RARITAN, N.J., August 21, 2008 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) today announced that the U.S. Food and Drug Administration (FDA) requires additional information before it will...
SUMMIT, N.J.--(BUSINESS WIRE)--Aug 21, 2008 - Celgene Corporation (Nasdaq:CELG) today announced VIDAZA (azacitidine) received expanded U.S. Food and Drug Administration (FDA) approval to reflect new overall survival achieved in the AZA-001 survival...
SAN DIEGO--(BUSINESS WIRE)--Aug 20, 2008 - A Virginia man yesterday filed what is believed to be the first personal injury lawsuit stemming from injuries associated with the use of Byetta(R), an injectable medication for diabetes. Victor Deleon...
Elotuzumab Antibody Designed to Target Highly Expressed Cell Surface Protein and Selectively Kill Multiple Myeloma Cells
//
PRINCETON, N.J. & REDWOOD CITY, Calif., August 19, 2008 - Bristol-Myers Squibb Company (NYSE: BMY) and PDL...
New Drug Approvals
WASHINGTON, August 15, 2008 /PRNewswire/ -- Prestwick Pharmaceuticals, Inc., a privately-held pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Xenazine (tetrabenazine) for the treatment of chorea...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Aug 11, 2008 - Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Viread (tenofovir disoproxil fumarate) for the treatment of chronic...
First New IV Antihypertensive Treatment Approved in Ten Years
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company announced today that the U.S. Food and Drug Administration (FDA) has approved the intravenous (IV) therapy Cleviprex (clevidipine...
Approvals consistent with current US treatment guidelines to start appropriate patients on combination therapies
EAST HANOVER, N.J., August 04, 2008 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved two single-pill combination...
CEDAR KNolls, NJ, Aug. 1, 2008-EKR Therapeutics, Inc., a specialty pharmaceutical company focused on providing novel products for the acute-care hospital setting, today announced that it received FDA approval for Cardene I.V. (nicardipine...
New Drug Applications
VANCOUVER and DEERFIELD, IL, August 11, 2008 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. and its co-development partner Astellas Pharma US, Inc. ("Astellas") today announced that they have received an action letter dated August 8, 2008 from the...
BRIDGEWATER, N.J., August 08, 2008 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that U.S. Food and Drug Administration (FDA) has assigned priority review status for its New Drug Application (NDA) for Multaq (dronedarone). The priority...
HORSHAM, Pa., August 08, 2008 /PRNewswire/ -- Centocor, Inc., today announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline for the Biologic License Application for ustekinumab, a subcutaneous biologic therapy, by...
EXTON, Pa.--(BUSINESS WIRE)--Jul 30, 2008 - Othera Pharmaceuticals, Inc., announced today the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for OT-730, an oculoselective beta-blocker, as a...
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Aug 7, 2008 - GTC Biotherapeutics, Inc. has completed its submission of the final portion of the Biologics License Application, or BLA, for ATryn in the United States. The final portion of the BLA submission...
Clinical Trials
LONDON, Aug. 20, 2008--A new drug for cystic fibrosis, PTC124, can bypass the genetic defect in the protein-making machinery of patients and improve the functioning of cell membranes that is normally hampered by the condition. These are the...
CRANBURY, N.J.--(BUSINESS WIRE)--Aug 21, 2008 - VaxInnate Corporation announced today that its M2e universal influenza vaccine candidate was safe and immunogenic in its first Phase I clinical trial, raising hopes for a universal influenza vaccine...
WEIZMANN SCIENCE PARK, NESS ZIONA, Israel--(BUSINESS WIRE)--Aug. 21, 2008 - Kamada (TASE: KMDA), a bio-pharmaceutical company (www.kamada.com) engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced...
GLASGOW, Scotland--(BUSINESS WIRE)--Aug. 21, 2008 - Javelin Pharmaceuticals, Inc. (Amex: JAV), a leading developer of novel products for pain management, today presented new and successful secondary endpoint data from a previously announced pivotal...
CORAL GABLES, Fla., Aug 21, 2008 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. today reported that animal data from a new study sponsored by scientists at the U.S. Department of Energy's Brookhaven National Laboratory appears...
More News Resources
Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
